Users Online: 575
Home Print this page Email this page
Home About us Editorial board Search Browse articles Submit article Ahead of Print Instructions Subscribe Contacts Special issues Login 
CASE REPORT
Year : 2022  |  Volume : 11  |  Issue : 1  |  Page : 105

Treatment of hydatidiform mole suspected to COVID 19


1 Tropical and Communicable Diseases Research Center, Iranshahr University of Medical Sciences; Department of Midwifery, Iranshahr University of Medical Sciences, Iranshahr, Iran
2 Department of Midwifery, School of Nursing and Midwifery, Maternal – Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3 Department of Surgery, Iranshahr University of Medical Sciences, Iranshahr, Iran
4 Department of Obstetrics and Gynecology, Iranshahr University of Medical Sciences, Iranshahr, Iran
5 Department of Infectious Diseases, Iranshahr University of Medical Sciences, Iranshahr, Iran
6 Department of Internal Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran
7 Department of Midwifery, Iranshahr University of Medical Sciences, Iranshahr, Iran

Correspondence Address:
Dr. Saeedeh Rigiyousefabadi
Tropical and Communicable Diseases Research Center, Department of Midwifery, Iranshahr University of Medical Sciences, Iranshahr
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/abr.abr_142_21

Rights and Permissions

The aim of this study was to report a case of the treatment of hydatidiform mole in Coronavirus pandemic in Iranshahr. A 17-year-old primiparous woman with gestational age of 14 weeks presented with unilateral leg swelling and sudden abdominal distension beginning in the night before referring to the health center. In the abdominal examination of the patient by a healthcare provider, the baby's heartbeat was not heard and a mismatch was observed between gestational age and fundal height, which corresponded to approximately 24 weeks of gestation. She was conscious and pale with hematuria and uterine contractions. After inserting two IV lines, the patient immediately underwent monitoring and was visited by a gynecologist. Complete molar pregnancy was diagnosed with an enlarged heterogeneous uterus 180 cm × 90 cm in size and containing 170 mm × 80 mm cysts. The treatment began with vancomycin AMP, hydrocortisone AMP, oseltamivir CAP 75 mg, kaletra CAP 200 mg, and meropenem AMP.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed368    
    Printed26    
    Emailed0    
    PDF Downloaded60    
    Comments [Add]    

Recommend this journal